“Medicare Advantage plans, an alternative to the government-run, original Medicare program, are operated by private insurance companies…. “Insurers receive a monthly payment from the federal government for each enrollee, regardless of how much care they need. According to the Department of Health and Human […]
“On a hot July morning, customers at the Dollar General along a two-lane highway northwest of Nashville didn’t seem to notice signs of the chain store’s foray into mobile health care, particularly in rural America.” What Mobile Clinics in Dollar General […]
Online Education & Discussion Death vs. Dollars – Is Our Health an Individual or a Collective Responsibility? October 10 from 12 to 1 pm PT Sponsored by SF Bay Area League of Women Voters Featuring Dr. Sarah Rudman and Kimi Watkins-Tartt Click to register […]
“Not only are such deals more common, they can increase costs for patients. Merged hospitals in the same state but in different markets raised prices as much as 10% compared with other hospitals, researchers found after analyzing past deals. A separate study found stand-alone hospitals raised prices […]
“…a shutdown could complicate the lives of everyone who interacts with any federal health program, as well as the people who work at the agencies administering them.” What Happens to Health Programs if the Federal Government Shuts Down? For the first […]
Breaking News in Healthcare Reform Snippets of news & commentary with a special focus on health policy, Medicare for All & California _________________________________________________________________________________________________ Like Weekly News Roundup? Then you’ll love our popular podcast Code WACK! where we shine a light on the […]
The Biden administration announced a major initiative to protect Americans from medical debt on Thursday, outlining plans to develop federal rules barring unpaid medical bills from affecting patients’ credit scores. Biden Administration to Ban Medical Debt From Americans’ Credit Scores The regulations, […]
“Humira has enjoyed high-priced U.S. exclusivity for 20 years. Its challengers could save the health care system $9 billion and herald savings from the whole class of drugs called biosimilars — a windfall akin to the hundreds of billions saved each year through the […]
